Rewalk Robotics (RWLK) Trading Down 4.5%

Share on StockTwits

Rewalk Robotics Ltd (NASDAQ:RWLK) shares fell 4.5% during mid-day trading on Wednesday . The company traded as low as $0.21 and last traded at $0.21. 23,800 shares were traded during trading, a decline of 100% from the average session volume of 6,997,560 shares. The stock had previously closed at $0.22.

A number of analysts have recently weighed in on RWLK shares. Zacks Investment Research downgraded shares of Rewalk Robotics from a “buy” rating to a “hold” rating in a report on Thursday, October 25th. ValuEngine raised shares of Rewalk Robotics from a “sell” rating to a “hold” rating in a report on Wednesday, January 2nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company. Rewalk Robotics has a consensus rating of “Hold” and a consensus price target of $1.56.

The firm has a market capitalization of $8.02 million, a price-to-earnings ratio of -0.22 and a beta of 0.81.

Rewalk Robotics (NASDAQ:RWLK) last issued its quarterly earnings results on Thursday, November 8th. The medical device company reported ($0.13) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.14) by $0.01. Rewalk Robotics had a negative net margin of 352.11% and a negative return on equity of 3,654.32%. The company had revenue of $1.62 million during the quarter, compared to the consensus estimate of $2.12 million.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Fairfield Current and is the sole property of of Fairfield Current. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://www.fairfieldcurrent.com/news/2019/01/11/rewalk-robotics-rwlk-trading-down-4-5.html.

About Rewalk Robotics (NASDAQ:RWLK)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.

Featured Story: Terms to Better Understand Call Options

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply